FDA Adverse Event Injury Summary report: N

ALLURA XPER FD20

MDR report key: 10344241 · Received July 30, 2020

Report

Report Number
3003768277-2020-00044
Event Type
Injury
Date Received
July 30, 2020
Date of Event
June 22, 2020
Report Date
July 14, 2020
Manufacturer
PHILIPS HEALTHCARE
Product Code
OWB
UDI-DI
00884838054202
PMA / PMN Number
K141979
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 0

PHILIPS INSPECTED THE SYSTEM ON SITE AND IT WAS CONFIRMED THAT THE SYSTEM WAS WORKING ACCORDING TO SPECIFICATIONS. NO MALFUNCTION OF THE SYSTEM WAS IDENTIFIED VIA INSPECTION AND TESTING OF THE SYSTEM. PHILIPS ANALYZED THE LOG FILES OF THE SYSTEM AND CALCULATED THAT THE PATIENT RECEIVED A RADIATION DOSE OF 8.2 GY. AS ALSO SPECIFIED IN THE INSTRUCTIONS FOR USE (4522 203 29802, CHAPTER 2.1) DETERMINISTIC EFFECTS OR TISSUE REACTIONS MAY OCCUR WHEN THE RADIATION DOSE HAS EXCEEDED A CERTAIN THRESHOLD LEVEL. THE THRESHOLD DOSE IS TYPICALLY 2 GY FOR TRANSIENT SKIN ERYTHEMA (REDNESS OF THE SKIN) AND 3 GY FOR TEMPORARY HAIR LOSS. ANALYSIS OF THE LOG FILES DID NOT IDENTIFY ANY ERRORS OR ISSUES WITH THE SYSTEM. BASED ON THE INVESTIGATION RESULTS, PHILIPS HAS CONCLUDED THAT THERE WAS NO MALFUNCTION OF THE SYSTEM. SUBMISSION OF A REPORT DOES NOT CONSTITUTE AN ADMISSION THAT MEDICAL PERSONNEL, USER FACILITY, IMPORTER, DISTRIBUTOR, MANUFACTURER, OR PRODUCT CAUSED OR CONTRIBUTED TO THE EVENT.

Additional Manufacturer Narrative · 1

THE INVESTIGATION IS STILL ONGOING FOR THIS EVENT. WHEN THE INVESTIGATION IS COMPLETED A FOLLOW-UP WILL SENT TO THE FDA.

Description of Event or Problem · 1

IT WAS REPORTED TO PHILIPS AFTER A NEURO PROCEDURE THE PATIENT EXPERIENCED HAIR LOSS. PHILIPS HAS STARTED AN INVESTIGATION OF THIS COMPLAINT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
809171 ALLURA XPER FD20 INTERVENTIONAL FLUOROSCOPIC X-RAY SYSTEM OWB PHILIPS HEALTHCARE 722028 00884838054202

Patients

Seq Age Sex Outcome Treatment
1 32 YR Other